Search Results

Drugs Used to Treat Parkinson's Disease, Present Status and Future Directions

Author: Abdel-Salam, Omar M.E.

Source: CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets, Volume 7, Number 4, October 2008 , pp. 321-342(22)

Publisher: Bentham Science Publishers

Pharmacokinetic-Pharmacodynamic Interaction between Nebicapone, a Novel Catechol-O-Methyltransferase Inhibitor, and Controlled-Release Levodopa/Carbidopa 200 mg/50 mg: Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Subjects

Authors: Vaz-da-Silva, Manuel; Loureiro, Ana I.; Nunes, Teresa; Lopes, Carlos; Rocha, José; Machado, Rita; Costa, Raquel; Torrão, Leonel; Falcão, Amílcar; Wright, Lyndon; Almeida, Luis; Soares-da-Silva, Patrício

Source: Drugs in R&D, Volume 9, Number 6, 2008 , pp. 435-446(12)

Publisher: Adis International

Impact of Newer Pharmacological Treatments on Quality of Life in Patients with Parkinson's Disease

Authors: Gallagher, David A.; Schrag, Anette

Source: CNS Drugs, Volume 22, Number 7, 2008 , pp. 563-586(24)

Publisher: Adis International

Evidence-Based Efficacy Comparison of Tolcapone and Entacapone as Adjunctive Therapy in Parkinson's Disease

Author: Lees, Andrew J.

Source: CNS Drug Reviews, Volume 14, Number 1, Spring 2008 , pp. 83-93(11)

Publisher: Blackwell Publishing

Manage levodopa-induced motor complications in patients with Parkinson's disease with careful selection of other antiparkinsonian agents

Author: Adis International Limited,

Source: Drugs & Therapy Perspectives, Volume 24, Number 1, January 2008 , pp. 17-21(5)

Publisher: Adis International

Constant dopaminergic stimulation by transdermal delivery of dopaminergic drugs: a new treatment paradigm in Parkinson's disease

Author: Steiger, M.

Source: European Journal of Neurology, Volume 15, Number 1, January 2008 , pp. 6-15(10)

Publisher: Blackwell Publishing

The Evolution of Pharmacological Treatment for Parkinson's Disease

Authors: Almeida, Quincy J.; Hyson, H. C.

Source: Recent Patents on CNS Drug Discovery, Volume 3, Number 1, January 2008 , pp. 50-54(5)

Publisher: Bentham Science Publishers

Drug-drug interactions with levodopa modulating treatment responses in Parkinson's disease

Author: Haefeli, Walter

Source: Journal of Neurology, Volume 254, Supplement 1, August 2007 , pp. IV29-IV36(1)

Publisher: Springer

Role of tolcapone in the treatment of Parkinson's disease

Authors: Leegwater-Kim, Julie; Waters, Cheryl

Source: Expert Review of Neurotherapeutics, Volume 7, Number 12, December 2007 , pp. 1649-1657(9)

Publisher: Expert Reviews

Catechol-O-methyltransferase and Its Inhibitors in Parkinson's Disease

Authors: Bonifácio, Maria João; Palma, P. Nuno; Almeida, Luís; Soares-da-Silva, Patrício

Source: CNS Drug Reviews, Volume 13, Number 3, Fall 2007 , pp. 352-379(28)

Publisher: Blackwell Publishing

Community and Long-Term Care Management of Parkinson's Disease in the Elderly: Focus on Monoamine Oxidase Type B Inhibitors

Authors: Chen, Jack J.; Fernandez, Hubert H.

Source: Drugs & Aging, Volume 24, Number 8, 2007 , pp. 663-680(18)

Publisher: Adis International

Medical Management of Levodopa-Associated Motor Complications in Patients with Parkinson's Disease

Authors: Jankovic, Joseph; Stacy, Mark

Source: CNS Drugs, Volume 21, Number 8, 2007 , pp. 677-692(16)

Publisher: Adis International

Treatment of Cognitive Deficits Associated with Schizophrenia: Potential Role of Catechol-O-Methyltransferase Inhibitors

Authors: Apud, José A.; Weinberger, Daniel R.

Source: CNS Drugs, Volume 21, Number 7, 2007 , pp. 535-557(23)

Publisher: Adis International

The patient with Parkinson's disease: Part I-Treating the motor symptoms;

Authors: Snyder, Charlene Hoffman; Adler, Charles H.

Source: Journal of the American Academy of Nurse Practitioners, Volume 19, Number 4, April 2007 , pp. 179-197(19)

Publisher: Blackwell Publishing

Existing dopaminergic therapies for Parkinson's disease

Authors: Dutta PhD, Aloke K; Le MD PhD, Weidong

Source: Expert Opinion on Therapeutic Patents, Volume 16, Number 12, December 2006 , pp. 1613-1625(13)

Publisher: Informa Healthcare

Tolcapone in the management of Parkinson's disease

Author: Müller, Thomas

Source: Aging Health, Volume 2, Number 5, October 2006 , pp. 709-720(12)

Publisher: Future Medicine

Pharmacokinetic Optimisation in the Treatment of Parkinson's Disease: An Update

Author: Nyholm, Dag

Source: Clinical Pharmacokinetics, Volume 45, Number 2, 2006 , pp. 109-136(28)

Publisher: Adis International

Inhibition of DNA methylation by caffeic acid and chlorogenic acid, two common catechol-containing coffee polyphenols

Authors: Lee, Won Jun; Zhu, Bao Ting

Source: Carcinogenesis, Volume 27, Number 2, 1 February 2006 , pp. 269-277(9)

Publisher: Oxford University Press

Genetics and Epigenetics in Major Psychiatric Disorders: Dilemmas, Achievements, Applications, and Future Scope

Authors: Abdolmaleky, Hamid M.; Thiagalingam, Sam; Wilcox, Marsha

Source: American Journal of PharmacoGenomics, Volume 5, Number 3, 2005 , pp. 149-160(12)

Publisher: Adis International

Tolcapone in Parkinson’s disease: liver toxicity and clinical efficacy

Author: Nuno Borges

Source: Expert Opinion on Drug Safety, Volume 4, Number 1, 1 January 2005 , pp. 69-73(5)

Publisher: Informa Healthcare